<div id="readability-page-1"><div>Piscitelli Dominic Chief Financial Officer of Oric Pharmaceuticals Inc [ORIC] filed a Form 4 on December 17, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:<div><table><tbody><tr><th>Date</th><th>Transaction</th><th>Shares</th><th>Price</th><th>Value</th></tr><tr><td>12/15/25</td><td>Exercise</td><td>29,333</td><td>$0.00</td><td>N/A</td></tr><tr><td>12/16/25</td><td>Surrender(1)</td><td>10,720</td><td>$9.06</td><td>$97,127</td></tr></tbody></table></div>Ending Holdings: 68,148 - Direct<ul><li>(1)</li><li>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</li></ul>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data. </div></div>

ORIC

CFO Dominic Piscitelli of Oric Pharmaceuticals Inc filed a Form 4 with the SEC, disclosing changes in ownership. On December 15, 2025, he exercised 29,333 shares at $0.00, and on December 16, 2025, surrendered 10,720 shares at $9.06, valued at $97,127, to cover option exercise costs and/or tax liabilities. His ending direct holdings are 68,148 shares.

CFO Piscitelli Acquires 18,613 Of Oric Pharmaceuticals Inc [ORIC]